Methods of treating cancer by targeting tumor-associated macrophages
US-2024415921-A1 · Dec 19, 2024 · US
US9370589B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9370589-B2 |
| Application number | US-201113818392-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 8, 2011 |
| Priority date | Aug 23, 2010 |
| Publication date | Jun 21, 2016 |
| Grant date | Jun 21, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a novel fluorescent nanoparticle imaging probe having a switching function (a function to quench a fluorescent dye during nanoparticle preparation, and emit fluorescence during imaging). A switching fluorescent nanoparticle probe comprising: a molecular assembly composed of an amphiphilic block polymer having a hydrophilic block chain and a hydrophobic block chain; and a fluorescent dye encapsulated in the molecular assembly, wherein (a) the hydrophilic block chain comprises, as an essential hydrophilic structural unit, a unit selected from a sarcosine unit and an alkylene oxide unit, (b) the hydrophobic block chain comprises, as an essential hydrophobic structural unit, a unit selected from the group consisting of an amino acid unit and a hydroxylic acid unit, and (c) the fluorescent dye is a cyanine compound represented by the formula (I): and two or more molecules of the fluorescent dye are encapsulated in the single molecular assembly.
Opening claim text (preview).
The invention claimed is: 1. A fluorescent nanoparticle probe comprising: a molecular assembly composed of an amphiphilie block polymer having a hydrophilic block chain and a hydrophobic block chain; and a fluorescent dye encapsulated in the molecular assembly, wherein the amphiphilic block polymer is selected from the group consisting of a polysarcosine-polylactic acid amphiphilic block polymer, a polyethylene glycol-polylactic acid amphiphilic block polymer, and a polysarcosine-poly (leucine-aminoisobutyric acid) amphiphilic block polymer, and the fluorescent dye is a cyanine compound represented by the following structural formula (I); wherein R 1 and R 2 may be the same or different from each other and each is a hydrocarbon group Which may be substituted; R 3 is a bivalent hydrocarbon group which may be substituted; X is a halogen, an aryloxy group, or a thioaryloxy group; A − is an anion and m is 0 or 1; and a ring B and a ring D may be the same or different from each other and each is a nitrogen containing bicyclic or tricyclic aromatic heterocycle, and two or more molecules of the fluorescent dye are encapsulated in a self-quenching state by association in the single molecular assembly, wherein the fluorescent nanoparticle recovers fluorescence by contact with a blood component to deform the structure of the molecular assembly composed of an amphiphilic block polymer and to dissociate the association of the two or more molecules of the fluorescent dye; and wherein fluorescence intensity in plasma is 10 times or more higher than that in phosphate buffered saline. 2. The fluorescent nanoparticle probe according, to claim 1 , wherein the fluorescent dye is encapsulated in the molecular assembly in an amount of 1to 50 mol % with respect to a total amount of the amphiphilic block polymer and the fluorescent dye. 3. The fluorescent nanoparticle probe according to claim 1 , wherein the ring B has either of the following structures: wherein R 4 and R 5 are hydrogen or are linked together to form an aryl ring; and the ring D has either of the following structures: wherein R 4 and R 5 are hydrogen or are linked together to form an aryl ring. 4. The fluorescent nanoparticle probe according to claim 1 , wherein the cyanine compound is an indocyanine compound represented by the following structural formula (I-i): wherein R 4 and R 5 are hydrogen or are linked together to form an aryl ring. 5. The fluorescent nanoparticle probe according to claim 1 , wherein the fluorescent dye is represented by the following structural formula (I-ii): 6. The fluorescent nanoparticle probe according to claim 1 , wherein the fluorescent dye is represented by the following structural formula (I-iii): 7. The fluorescent nanoparticie probe according to claim 1 , wherein the fluorescent dye is represented by the following structural formula (I-iv): 8. The fluorescent nanoparticle probe according to claim 1 , wherein the fluorescent dye is represented by the following structural formula (I-v): 9. The fluorescent nanoparticle probe according to claim 1 , wherein the fluorescent dye is represented by the following structural formula (I-vi): 10. The fluorescent nanoparticle probe according to claim 1 , wherein the fluorescent dye is represented by the following structural formula (I-vii): 11. The fluorescent nanoparticle probe according to claim 1 , wherein the fluorescent dye is represented by the following structural formula (I-viii): 12. The fluorescent nanoparticle probe according to claim 1 , wherein the fluorescent dye is represented by the following structural formula (I-ix): 13. The fluorescent nanoparticle probe according to claim 1 , wherein the fluorescent dye is represented by the following structural rafinula (I-x): 14. The fluorescent nanoparticie probe according to claim 1 , wherein the fluorescent dye is represented by the following structural formula (I-xi): 15. The fluorescent nanoparticle probe according to claim 1 , wherein the hydrophobic block chain is a hydrophobic block chain having 25 or more lactic acid units. 16. A fluorescent molecular imaging method comprising the steps of: administering the fluorescent nanopartiele probe according to claim 1 to a non-human animal; and detecting fluorescence.
Diagnostic contrast agent · CPC title
Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle · CPC title
Nanoparticle, i.e. structure having three dimensions of 100 nm or less · CPC title
Methine dyes, e.g. cyanine dyes · CPC title
Particulate, powder, adsorbate, bead, sphere · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.